Loading data
ATMUNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.76 bn USD | 1.67 bn USD | 1.63 bn USD | 1.56 bn USD | 1.44 bn USD |
| Cost of revenue | 1.27 bn USD | 1.21 bn USD | 1.2 bn USD | 1.2 bn USD | 1.09 bn USD |
| Gross profit | 498.3 m USD | 462.1 m USD | 432.7 m USD | 359.2 m USD | 349.3 m USD |
| Research and development expense | 40.7 m USD | 40.6 m USD | 42.5 m USD | 38.6 m USD | 42 m USD |
| Selling, general and administrative expense | 184.3 m USD | 187.6 m USD | 174.7 m USD | 139.7 m USD | 126.2 m USD |
| Operating profit | 299 m USD | 266.2 m USD | 248.4 m USD | 203.9 m USD | 213.5 m USD |
| Interest expense | — | — | 25.8 m USD | 700 k USD | 800 k USD |
| Profit before tax | 266.2 m USD | 234.8 m USD | 226.4 m USD | 212 m USD | 216.6 m USD |
| Income tax expense | 58.8 m USD | 49.2 m USD | 55.1 m USD | 41.6 m USD | 46.5 m USD |
| Net income (reported basis) | 207.4 m USD | 185.6 m USD | 171.3 m USD | 170.4 m USD | 170.1 m USD |
| Basic earnings per share | 2.52 USD/share | 2.23 USD/share | 2.06 USD/share | 2.05 USD/share | 2.04 USD/share |
| Diluted earnings per share | 2.5 USD/share | 2.22 USD/share | 2.05 USD/share | 2.05 USD/share | 2.04 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.